Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
A continuous subcutaneous insulin pump replaces the need for multiple daily injections by delivering rapid acting insulin to a patient 24 hours a day. Our most advanced insulin pump, the MiniMed™ 770G system, is automated, connected, and upgradeable so that you can focus on patient care.
The MiniMed™ 770G system features SmartGuardTM Auto Mode, which automatically adjusts insulin every 5 minutes based on the patient’s unique needs.* With Bluetooth® connectivity, the system is able to connect to a smartphone, allowing patients and their care partners to view insulin pump and continuous glucose monitoring (CGM) data remotely.
Explore the MiniMed™ 770G Pump System - (26:23)
See how the MiniMed™ 770G system works and how it can help your patients maintain healthy sugar levels.
More information (see more)
Less information (see less)
Important Safety Information for MiniMed™ 770G System:
The MiniMed™ 770G system is for type 1 ages 2 and over. Prescription required. Individual results may vary. WARNING: Do not use SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of insulin/day. For details, please visit http://www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation for complete details.
The MiniMed™ 630G system has an intuitive design and several convenient features that can help your patients with type 2 and type 1 diabetes. It delivers continuous and customized doses of rapid-acting insulin 24 hours a day to match body’s needs.
Transitioning MDI patients with Type 2 Diabetes to Insulin Pump Therapy
Dr. LaShelle Barmore, D.O. discusses the effectiveness of insulin pump therapy particularly for people with type 2 diabetes and how to transition patients from injections.
Important Safety Information for MiniMed™ 630G System:
Indicated for the continuous delivery of insulin, at set and variable rates, for the management of diabetes mellitus. The MiniMed™ 630G system is approved for ages 14 and up with Guardian™ Sensor 3. The system requires a prescription. WARNING: Do not use the Suspend on low feature to prevent or treat low blood glucose. For details, please visit http://www.medtronicdiabetes.com/support/download-library/user-guides and www.medtronicdiabetes.com/importantsafetyinformation for complete details.
